Cargando…

Epstein-Barr virus EBNA2 directs doxorubicin resistance of B cell lymphoma through CCL3 and CCL4-mediated activation of NF-κB and Btk

Epstein-Barr virus (EBV)-encoded nuclear antigen, EBNA2, expressed in EBV-infected B lymphocytes is critical for lymphoblastoid cell growth. Microarray profiling and cytokine array screening revealed that EBNA2 is associated with upregulation of the chemokines CCL3 and CCL4 in lymphoma cells. Deplet...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Joo Hyun, Kim, Won Seog, Hong, Jung Yong, Ryu, Kung Ju, Kim, Seok Jin, Park, Chaehwa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354914/ https://www.ncbi.nlm.nih.gov/pubmed/28036258 http://dx.doi.org/10.18632/oncotarget.14243

Ejemplares similares

NF-κB Signaling Regulates Epstein–Barr Virus BamHI-Q-Driven EBNA1 Expression
por: Verhoeven, Rob J. A., et al.
Publicado: (2018)

Epstein-Barr virus-encoded EBNA1 inhibits the canonical NF-κB pathway in carcinoma cells by inhibiting IKK phosphorylation
por: Valentine, Robert, et al.
Publicado: (2010)

The Epstein-Barr Virus EBNA1 Protein
por: Frappier, Lori
Publicado: (2012)

Potential Cellular Functions of Epstein-Barr Nuclear Antigen 1 (EBNA1) of Epstein-Barr Virus
por: Smith, Danielle Westhoff, et al.
Publicado: (2013)

Bindarit Reduces Bone Loss in Ovariectomized Mice by Inhibiting CCL2 and CCL7 Expression via the NF‐κB Signaling Pathway
por: Yuan, Shi‐guo, et al.
Publicado: (2022)

Lymphomas driven by Epstein-Barr virus nuclear antigen-1 (EBNA1) are dependant upon Mdm2
por: AlQarni, Sana, et al.
Publicado: (2018)

Ashwagandha attenuates TNF-α- and LPS-induced NF-κB activation and CCL2 and CCL5 gene expression in NRK-52E cells
por: Grunz-Borgmann, Elizabeth, et al.
Publicado: (2015)

Contributions of Epstein–Barr Nuclear Antigen 1 (EBNA1) to Cell Immortalization and Survival
por: Frappier, Lori
Publicado: (2012)

The Epstein-Barr virus EBNA1 protein modulates the alternative splicing of cellular genes
por: Boudreault, Simon, et al.
Publicado: (2019)

Carcinoma-risk variant of EBNA1 deregulates Epstein-Barr Virus episomal latency
por: Dheekollu, Jayaraju, et al.
Publicado: (2017)

Epstein–Barr virus envelope glycoprotein 110 inhibits NF-κB activation by interacting with NF-κB subunit p65
por: Cai, Mingsheng, et al.
Publicado: (2023)

NF-κB directly mediates epigenetic deregulation of common microRNAs in Epstein-Barr virus-mediated transformation of B-cells and in lymphomas
por: Vento-Tormo, Roser, et al.
Publicado: (2014)

Epstein-Barr virus nuclear protein EBNA3C directly induces expression of AID and somatic mutations in B cells
por: Kalchschmidt, Jens S., et al.
Publicado: (2016)

Raloxifene Suppresses Experimental Autoimmune Encephalomyelitis and NF-κB-Dependent CCL20 Expression in Reactive Astrocytes
por: Li, Rui, et al.
Publicado: (2014)

NF-κB-Mediated CCL20 Reigns Dominantly in CXCR2-Driven Ovarian Cancer Progression
por: Ignacio, Rosa Mistica C., et al.
Publicado: (2016)

CCL3 Promotes Proliferation of Colorectal Cancer Related with TRAF6/NF-κB Molecular Pathway
por: Ma, Xiaoqiang, et al.
Publicado: (2022)

Cordycepin induces apoptosis of human ovarian cancer cells by inhibiting CCL5-mediated Akt/NF-κB signaling pathway
por: Cui, Zhen Yang, et al.
Publicado: (2018)

An EBNA3C-deleted Epstein-Barr virus (EBV) mutant causes B-cell lymphomas with delayed onset in a cord blood-humanized mouse model
por: Romero-Masters, James C., et al.
Publicado: (2018)

Epstein−Barr virus-encoded EBNA2 alters immune checkpoint PD-L1 expression by downregulating miR-34a in B-cell lymphomas
por: Anastasiadou, Eleni, et al.
Publicado: (2018)

Correction: Carcinoma-risk variant of EBNA1 deregulates Epstein-Barr Virus episomal latency
por: Dheekollu, Jayaraju, et al.
Publicado: (2019)

EBNA1-targeted inhibitors: Novel approaches for the treatment of Epstein-Barr virus-associated cancers
por: Jiang, Lijun, et al.
Publicado: (2018)

Chrysin Inhibits NF-κB-Dependent CCL5 Transcription by Targeting IκB Kinase in the Atopic Dermatitis-Like Inflammatory Microenvironment
por: Yeo, Hyunjin, et al.
Publicado: (2020)

Lirioresinol B dimethyl ether inhibits NF-κB and COX-2 and activates IκBα expression in CCl(4)-induced hepatic fibrosis
por: Shehzad, Adeeb, et al.
Publicado: (2020)

Impaired Control of Epstein–Barr Virus Infection in B-Cell Expansion with NF-κB and T-Cell Anergy Disease
por: Arjunaraja, Swadhinya, et al.
Publicado: (2018)

TWEAK Activates the Non-Canonical NFκB Pathway in Murine Renal Tubular Cells: Modulation of CCL21
por: Sanz, Ana B., et al.
Publicado: (2010)

HMGA1 Promotes Macrophage Recruitment via Activation of NF-κB-CCL2 Signaling in Hepatocellular Carcinoma
por: Chen, Junming, et al.
Publicado: (2022)

Increased association between Epstein-Barr virus EBNA2 from type 2 strains and the transcriptional repressor BS69 restricts EBNA2 activity
por: Ponnusamy, Rajesh, et al.
Publicado: (2019)

CC chemokines CCL2, CCL3, CCL4 and CCL5 are elevated in osteoporosis patients
por: Farangis, Fatehi, et al.
Publicado: (2017)

An Epstein-Barr virus-specific cytotoxic T cell epitope in EBV nuclear antigen 3 (EBNA 3)
Publicado: (1990)

PRIMA-1(MET )induces nucleolar translocation of Epstein-Barr virus-encoded EBNA-5 protein
por: Stuber, György, et al.
Publicado: (2009)

STUB1 is targeted by the SUMO-interacting motif of EBNA1 to maintain Epstein-Barr Virus latency
por: Wang, Yuyan, et al.
Publicado: (2020)

Phase separation of Epstein-Barr virus EBNA2 protein reorganizes chromatin topology for epigenetic regulation
por: Yang, Yiting, et al.
Publicado: (2021)

EBNA1-Mediated Recruitment of a Histone H2B Deubiquitylating Complex to the Epstein-Barr Virus Latent Origin of DNA Replication
por: Sarkari, Feroz, et al.
Publicado: (2009)

Epstein-Barr virus nuclear antigen EBNA-LP is essential for transforming naïve B cells, and facilitates recruitment of transcription factors to the viral genome
por: Szymula, Agnieszka, et al.
Publicado: (2018)

The Epstein-Barr Virus Oncogene EBNA1 Suppresses Natural Killer Cell Responses and Apoptosis Early after Infection of Peripheral B Cells
por: Westhoff Smith, Danielle, et al.
Publicado: (2021)

Polydeoxyribonucleotide Exerts Protective Effect Against CCl(4)-Induced Acute Liver Injury through Inactivation of NF-κB/MAPK Signaling Pathway in Mice
por: Ko, Il-Gyu, et al.
Publicado: (2020)

The Correlation of Serums CCL11, CCL17, CCL26, and CCL27 and Disease Severity in Patients with Urticaria
por: Lu, Tao, et al.
Publicado: (2016)

CCL18 promotes the metastasis of squamous cell carcinoma of the head and neck through MTDH‐NF‐κB signalling pathway
por: Qin, Yuexiang, et al.
Publicado: (2019)

HIV integration and the establishment of latency in CCL19-treated resting CD4(+) T cells require activation of NF-κB
por: Saleh, Suha, et al.
Publicado: (2016)

BRD4 promotes tumor progression and NF-κB/CCL2-dependent tumor-associated macrophage recruitment in GIST
por: Mu, Jianfeng, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_vnvbhe6ic1r9om97i405equ75s